Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FuturHealth
San Diego, California, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Large real-world study (n=33,740) shows patients in the FuturHealth Program achieve significantly higher weight loss versus GLP-1 therapy alone—the combination of FuturHealth coaching plus GLP-1 therapy (semaglutide, tirzepatide) resulted in 12–13% average body weight loss over 6 months, >25–30 lbs lost, and more robust BMI reduction than medication alone. Clinically driven program is delivered across 48 states by telehealth network of >6,000 providers.
- Therapeutic areas
- Endocrinology
- Modalities
- Small moleculeBiologic
- Industry
- Non-Academic Healthcare
02
Partnerships
ValisureAlto PharmacyFuze Health
Beyond the preview
Go deeper on FuturHealth.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on FuturHealth.